Abstract
To investigate effect of estradiol-17β (E 2) treatment in vivo on binding of eel hepatocytes to HDL, we developed hepatocytes binding assay. When hepatocytes were incubated with 200 times excess of eel HDL, the binding of hepatocytes to HDL precoated on wells was inhibited competitively. This indicates that eel hepatocytes bound specifically to HDL. E 2 treatment in vivo induced vitellogenin (VTG) synthesis. Hepatocytes prepared from the same E 2 treatment eel showed 3-fold higher ability of binding to HDL compared to hepatocytes prepared from ells without E 2 treatment. We also examined effects of E 2 and HDL on VTG induction in cultured hepatocytes. VTG, determined by enzyme-linked immunosorbent assay (ELISA), induction was about two-times higher in the presence of both 10 −5 M of E 2 and 400 μg of HDL than in the presence of 10 −5 M E 2 alone. At concentrations below 10 −6 M E 2, VTG was not induced in the presence or absence of HDL. By SDS–PAGE and immunoblotting, VTG was detected only in the presence of both 10 −5 M of E 2 and HDL. Our findings strongly support the idea that HDL correlates with vitellogenesis in eel liver.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.